| Name |
Flixonase sprej za nos, suspenzija |
| Marketing Authorisation Number |
HR-H-653844542 |
| Active Substance |
flutikazonpropionat |
| Composition |
1 g suspenzije sadrži 500 mikrograma flutikazonpropionata 1 inhalacijska doza sadrži 50 mikrograma flutikazonpropionata |
| Pharmaceutical Form |
sprej za nos, suspenzija |
| Packaging [MA Number for Packaging] |
120 doza suspenzije u bočici s odmjernim sustavom za raspršivanje, u kutiji [HR-H-653844542-01]
|
| Manufacturer |
Glaxo Wellcome S.A., Aranda de Duero, Burgos, Španjolska |
| Marketing Authorisation Holder |
GlaxoSmithKline Trading Services Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Irska |
| Marketing Authorisation Date |
20.08.2021 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/13-02/465 |
| Registration Number |
381-12-01/70-21-29 |
| Prescription |
na recept |
| Type of prescription |
ponovljivi recept
|
| Distribution |
u ljekarni |
| Advertising to general public |
zabranjeno |
| ATC Code |
R01AD08 |
| Medicinal product marketed in the Croatia |
Da |
| SmPC |
download |
| PL |
download |
